Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02752256 · ClinicalTrials.gov registry record
Thrombolytic Care During Inter-hospital Transfer
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 76
- Enrollment target
NCT02752256: Completed study, sponsored by University of Iowa.
NCT02752256 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02752256 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
Primary Outcome
Protocol violations can include any of the following recorded outcomes: inaccurate dosing or preparation at the outside hospital, uncontrolled blood pressure before and during the flight, unnecessary medication administration before and during the flight, intracranial bleeding, and angioedema
Interventions
- DRUG Tissue Plasminogen Activator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-10 |
What the finished NCT02752256 record still lists
NCT02752256 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tissue Plasminogen Activator is the first listed.
NCT02752256 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02752256 about?
NCT02752256 is a clinical study titled "Thrombolytic Care During Inter-hospital Transfer". Evaluation of ischemic stroke patients receiving tissue plasminogen activator (rtPA) during air ambulance transfer
What is the current status of trial NCT02752256?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2015-10. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02752256?
The interventions under investigation include: Tissue Plasminogen Activator (DRUG).
Who is sponsoring clinical trial NCT02752256?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia